Business context and reporting period
The supplied filing is Oxbridge Acquisition Corp.’s Form 10-K for the fiscal year ended December 31, 2022—not a Jet.AI Inc. filing. Oxbridge was a Cayman Islands SPAC and shell company with no operations or operating revenue, formed to pursue a business combination. Its stated focus included technology, blockchain and artificial intelligence businesses.
Financial position and results
- Revenue and profit: No operating revenue. 2022 net income was $7.18 million, compared with a restated net loss of $3.54 million for April 12–December 31, 2021. 2022 income included $6.70 million from the reduction in warrant-liability fair value and $0.96 million of trust-account interest, against $487,000 of general and administrative expense. Basic and diluted earnings per share were $0.546, versus a restated loss of $0.244.
- Cash flow: Operating activities used $403,000 in 2022. Cash at year-end was $212,000, down from $614,000 at December 31, 2021.
- Trust and liquidity: Trust assets were $12.83 million at year-end, including marketable securities; management reported working capital of approximately $110,000. The filing states that 1,186,952 Class A shares were subject to redemption at approximately $10.81 per share.
- Debt and obligations: A $575,000, non-interest-bearing sponsor extension note was outstanding, repayable upon a business combination or liquidation. Deferred underwriting commissions were $4.025 million and payable only if a business combination closes. No working-capital loans were outstanding.
- Warrants: Warrant liabilities fell to $370,000 from $7.07 million, driving most of the year’s reported profit. These fair-value changes are non-cash and depend on valuation inputs.
Material changes versus the prior period
In November 2022, shareholders extended the business-combination deadline from November 16, 2022, to August 16, 2023. The extension prompted substantial redemptions: the filing reports an aggregate $105.42 million redemption, but gives inconsistent share counts in different sections (10,313,048 and 10,318,048). Trust assets consequently declined from $116.73 million at December 31, 2021, to $12.83 million at December 31, 2022. Net income turned positive from the prior-period loss, principally because the warrant-liability revaluation changed from a loss to a gain.
Outlook, risks and unusual items
- Deadline and going concern: The company had until August 16, 2023, to complete a business combination or liquidate and redeem public shares. Management and the auditor cited substantial doubt about the company’s ability to continue as a going concern; success depended on completing a transaction and/or securing additional financing.
- Limited resources: Management said available working capital and borrowing capacity were expected to cover needs through a combination or six months from the filing, while also warning that cash outside the trust might be insufficient. Potential sponsor or affiliate loans were discretionary, not committed.
- Investor exposure: If no transaction closed by the deadline, public shares would be redeemed from the trust, subject to claims and applicable costs; warrants could expire worthless. The filing describes the expected liquidation amount as approximately $11.07 per share in certain risk disclosures, while the year-end redemption value was approximately $10.81 per share.
- Control weakness: Management concluded disclosure controls and internal control over financial reporting were ineffective due to a material weakness involving accounting for complex financial instruments. Remediation was underway, but completion and effectiveness were not assured. The 2021 comparative financial statements are identified as restated.
- Conflicts and dilution: Sponsor founder shares represented about 69% of outstanding ordinary shares after redemptions, and the sponsor held director-appointment rights before a combination. Management disclosed competing fiduciary obligations and other conflicts. Additional financing or securities issuance could dilute public holders.
- Other exposures: The filing cites competition for targets, limited transaction time and due diligence, possible third-party claims against trust assets, Nasdaq-listing risk, and regulatory uncertainty including proposed SEC SPAC rules. It says the effects of the Russia-Ukraine conflict and related sanctions were not determinable.
Key facts for investors to verify
- Confirm the correct issuer: the supplied 10-K is for Oxbridge Acquisition Corp., not Jet.AI Inc.
- Reconcile the conflicting reported redemption-share counts and verify the related trust-account balance and remaining public shares.
- Review the complete audited financial statements and restatement disclosures, including the warrant valuation assumptions and their effect on earnings.
- Check the status of the going-concern uncertainty, available cash outside the trust, sponsor-note repayment, and any subsequent financing or business-combination developments.
- Assess remediation of the material weakness and whether internal controls became effective after year-end.